The FDA approved PSMA-PET for prostate cancer imaging for UCLA and UCSF after a four-year collaboration. UCLA's team was led by Drs. Czernin and Calais.
"Dr. Tom Graeber and colleagues Drs. Antoni Ribas and Roger Lo received a $13M, five-year NIH grant to study melanoma resistance to targeted therapies and immun
